Powerful substances in tiny amounts: An interview study of psychedelic microdosing
- PMID: 32934512
- PMCID: PMC7434115
- DOI: 10.1177/1455072517753339
Powerful substances in tiny amounts: An interview study of psychedelic microdosing
Abstract
Aims: This article presents a qualitative interview study of people who microdose with psychedelic drugs, which means that the user takes about one tenth of an ordinary recreational dose.
Design: Respondents (n = 21) were recruited at several Internet fora for individual interviews via private messaging. Every participant was male, and the median respondent was in his 30s with a stable job and relationship and extensive entheogen experience.
Results: Respondents tended to experiment with microdosing in phases, reporting mostly positive consequences from this form of drug use. Reported effects included improved mood, cognition, and creativity, which often served to counteract symptoms especially from conditions of anxiety and depression. There were also reports of various challenges with psychedelic microdosing, and some did not find the practice worth continuing.
Conclusion: The study obtained evidence of a group of users taking small doses of psychedelics not for the purpose of intoxication but to enhance everyday functioning. While the study's findings are not generalisable, they may inform subsequent investigations with research questions and hypotheses.
Keywords: enhancement; health effects; interview; microdose; psychedelic; qualitative.
© The Author(s) 2018.
Conflict of interest statement
Declaration of conflicting interests: The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Self-blinding citizen science to explore psychedelic microdosing.Elife. 2021 Mar 2;10:e62878. doi: 10.7554/eLife.62878. Elife. 2021. PMID: 33648632 Free PMC article.
-
Microdosing psychedelics: Motivations, subjective effects and harm reduction.Int J Drug Policy. 2020 Jan;75:102600. doi: 10.1016/j.drugpo.2019.11.008. Epub 2019 Nov 25. Int J Drug Policy. 2020. PMID: 31778967
-
The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review.J Psychoactive Drugs. 2020 Sep-Oct;52(4):300-308. doi: 10.1080/02791072.2020.1761573. Epub 2020 May 2. J Psychoactive Drugs. 2020. PMID: 32362269 Review.
-
Cannabis as entheogen: survey and interview data on the spiritual use of cannabis.J Cannabis Res. 2020 Sep 22;2(1):30. doi: 10.1186/s42238-020-00032-2. J Cannabis Res. 2020. PMID: 33526128 Free PMC article.
-
Psychedelic Cognition-The Unreached Frontier of Psychedelic Science.Front Neurosci. 2022 Mar 15;16:832375. doi: 10.3389/fnins.2022.832375. eCollection 2022. Front Neurosci. 2022. PMID: 35401088 Free PMC article. Review.
Cited by
-
Repeated microdoses of LSD do not alter anxiety or boldness in zebrafish.Sci Rep. 2024 Feb 22;14(1):4389. doi: 10.1038/s41598-024-54676-8. Sci Rep. 2024. PMID: 38388550 Free PMC article.
-
Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.Harm Reduct J. 2019 Nov 28;16(1):63. doi: 10.1186/s12954-019-0333-3. Harm Reduct J. 2019. PMID: 31779667 Free PMC article.
-
The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study.Int Med Case Rep J. 2023 Mar 3;16:109-115. doi: 10.2147/IMCRJ.S395342. eCollection 2023. Int Med Case Rep J. 2023. PMID: 36896410 Free PMC article.
-
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.Psychopharmacology (Berl). 2022 Jun;239(6):1735-1747. doi: 10.1007/s00213-021-05991-9. Epub 2021 Oct 6. Psychopharmacology (Berl). 2022. PMID: 34613430 Free PMC article. Clinical Trial.
-
The Algorithms of Mindfulness.Sci Technol Human Values. 2022 Mar;47(2):291-313. doi: 10.1177/01622439211025632. Epub 2021 Jun 22. Sci Technol Human Values. 2022. PMID: 35103028 Free PMC article.
References
-
- Abramson H. A. (1967). The use of LSD in psychotherapy and alcoholism. New York, NY: Bobbs-Merril.
-
- Bargh J. A., McKenna K. Y. A., Fitzsimons G. M. (2002). Can you see the real me? Activation and expression of the “true self” on the Internet. Journal of Social Issues, 58(1), 33–48.
-
- Bogenschutz M. P., Forcehimes A. A., Pommy J. A., Wilcox C. E., Barbosa P. C. R., Strassman R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. doi:10.1177/0269881114565144 - PubMed
-
- Carhart-Harris R. L., Nutt D. J. (2010). User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Abuse, 15(4), 283–300. doi:10.3109/14659890903271624
-
- Corazza O., Bersani F. S., Brunoro R., Valeriani G., Martinotti G., Schifano F. (2014). The diffusion of Performance and Image-Enhancing Drugs (PIEDs) on the Internet: The abuse of the cognitive enhancer piracetam. Substance Use & Misuse, 49, 1849–1856. doi:10.3109/10826084.2014.912232 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources